Functionally-derivatized Nanoantibodies as novel tools for Giardia lamblia cyst detection
Corina D Wirdnam1, Timothé Schaerer1, Matthias Rubin2
1Institute of Cell Biology, University of Bern, Bern, Switzerland.
Insights
Researchers developed novel nanoantibodies for detecting Giardia lamblia cysts, improving diagnostics for this common diarrheal disease, especially in children. This offers a more accessible diagnostic tool for resource-limited settings.
Area of Science:
- Parasitology
- Immunology
- Biotechnology
Background:
- Giardiasis, caused by Giardia lamblia, is a significant diarrheal disease globally, particularly affecting children in resource-constrained areas.
- Current diagnostics like light microscopy are often insufficient, while advanced methods like ELISA with proprietary reagents are costly and inaccessible where most needed.
Purpose of the Study:
- To develop affordable and effective diagnostic tools for Giardia infections.
- To investigate novel strategies for detecting the Giardia cyst wall.
- To address medical equity issues in Giardiasis diagnostics.
Main Methods:
- Development and characterization of alpaca-derived single-domain antibodies (nanoantibodies) against Giardia lamblia cyst wall preparations.
- Evaluation of twelve unique E. coli-produced recombinant nanoantibody sequences for their binding capacity and effectiveness in detecting Giardia cysts.
Main Results:
- Successful development and characterization of novel nanoantibodies targeting the Giardia cyst wall.
- Demonstrated effectiveness of selected nanoantibodies in detecting Giardia cysts.
- Proof of concept for the versatility and utility of these protein domains in diagnostics.
Conclusions:
- Alpaca-derived nanoantibodies offer a promising, potentially more affordable alternative for Giardia cyst detection.
- These nanoantibodies can enhance diagnostic capabilities for Giardiasis, especially in resource-limited settings.
- The developed nanoantibodies provide a versatile tool for further research into Giardia cyst wall structure and function.
Abstract:
Giardia lamblia (syn. intestinalis, duodenalis) is the causative agent of Giardiasis, a diarrheal disease of global medical importance, especially problematic in young children living in unhygienic, resource-constrained settings. Diagnostics of potential Giardia infections are generally done through classic light-microscopy stool examination. This is often insufficient, and ELISA-based fluorescence detection using costly proprietary reagents is employed. These reagents are often not affordable in contexts where they are needed the most, and this limits their use to resource-rich settings where Giardiasis is rarely problematic. To address these issues in medical equity while designing novel strategies to investigate the Giardia cyst wall, we report on the development and characterisation of alpaca derived single-domain antibodies, known as nanoantibodies, elicited against G. lamblia enriched cyst-wall preparations. We evaluated the effectiveness and binding capacity of twelve unique E. coli-produced recombinant nanoantibody sequences for Giardia cyst wall detection and provide proof of concept for the effectiveness and versatility of these protein domains.
More Related Videos
09:08Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens
Published on: September 12, 2016
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
